Psychotropics and Hyperprolactinemia

Course overview

Hyperprolactinemia is a common side effect of antipsychotic medications that are used to treat chronic mental illnesses like schizophrenia and bipolar disorder. Insights into the physiological mechanisms of prolactin secretion, the effects of psychotropic drugs on prolactin levels, and the clinical consequences of hyperprolactinemia, including sexual and reproductive dysfunction, osteoporosis, and risks associated with prolactin-dependent tumors, are discussed. Therapeutic strategies, such as the use of dopamine agonists and partial agonists, to manage antipsychotic-induced hyperprolactinemia are raised. Through case studies, clinicians can better understand the practical challenges of treating hyperprolactinemia while maintaining psychiatric stability through proper treatment.